Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Lincoln Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Lincoln Pharmaceuticals Ltd Share Price Chart
Lincoln Pharmaceuticals Ltd Fundamentals
Traded Volume: 20,523
Market Cap(Cr): 1,060
Avg Traded Price 528.52
1 Year return -14.27%
Upper Circuit 534.7
Lower Circuit 524
P/E TTM 13.00
P/B Ratio 40.00
Traded Value(Cr) 108.59
EPS TTM 39.942
Book value 39.942
Dividend 0.00%
Lincoln Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Lincoln Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Lincoln Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +4.57%
1M +1.09%
3M -5.05%
1Y -14.27%
YTD -37.76%
Lincoln Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Lincoln Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 17315.00
Day Before Yesterday 18557.00
1W Avg 24759.20
1M Avg 25106.14
3M Avg 23477.71
Lincoln Pharmaceuticals Ltd Technical Details
Lincoln Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 524
Support 2 519
Support 3 513
Pivot Point : 529
Resistance 1 535
Resistance 2 540
Resistance 3 545
Lincoln Pharmaceuticals Ltd Corporate Actions
Lincoln Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Lincoln Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 12-Sep-2025 Type D Description 1.80/share@18.00% Record Date 12-Sep-2025 Ratio 18.00
Ex-Date 13-Sep-2024 Type D Description 1.80/share@18.00% Record Date - Ratio 18.00
Ex-Date 15-Sep-2023 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 15-Sep-2022 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 16-Sep-2021 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 05-Mar-2020 Type D Description 1.50/share@15.00% Record Date 06-Mar-2020 Ratio 15.00
Ex-Date 19-Sep-2019 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 19-Sep-2018 Type D Description 1.50/share@15.00% Record Date - Ratio 15.00
Ex-Date 21-Sep-2017 Type D Description 1.20/share@12.00% Record Date - Ratio 12.00
Ex-Date 23-Sep-2016 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 23-Sep-2015 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 25-Sep-2014 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 19-Sep-2013 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 20-Sep-2012 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 22-Sep-2011 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 23-Sep-2010 Type D Description 1.20/share@12.00% Record Date - Ratio 12.00
Ex-Date 17-Sep-2009 Type D Description 1.20/share@12.00% Record Date - Ratio 12.00
Ex-Date 19-Mar-2009 Type S Description share@1:0.20 Record Date 26-Mar-2009 Ratio 1:0.20
Ex-Date 18-Sep-2008 Type D Description 0.24/share@12.00% Record Date - Ratio 12.00
Ex-Date 20-Sep-2007 Type D Description 0.24/share@12.00% Record Date - Ratio 12.00
Dividends
Announcement Date 12-Sep-2025 Ex Dividend Date 12-Sep-2025 Dividend(%) 18
Announcement Date 13-Sep-2024 Ex Dividend Date 13-Sep-2024 Dividend(%) 18
Announcement Date 15-Sep-2023 Ex Dividend Date 15-Sep-2023 Dividend(%) 15
Announcement Date 15-Sep-2022 Ex Dividend Date 15-Sep-2022 Dividend(%) 15
Announcement Date 16-Sep-2021 Ex Dividend Date 16-Sep-2021 Dividend(%) 15
Announcement Date 05-Mar-2020 Ex Dividend Date 05-Mar-2020 Dividend(%) 15
Announcement Date 19-Sep-2019 Ex Dividend Date 19-Sep-2019 Dividend(%) 15
Announcement Date 19-Sep-2018 Ex Dividend Date 19-Sep-2018 Dividend(%) 15
Announcement Date 21-Sep-2017 Ex Dividend Date 21-Sep-2017 Dividend(%) 12
Announcement Date 23-Sep-2016 Ex Dividend Date 23-Sep-2016 Dividend(%) 10
Announcement Date 23-Sep-2015 Ex Dividend Date 23-Sep-2015 Dividend(%) 10
Announcement Date 25-Sep-2014 Ex Dividend Date 25-Sep-2014 Dividend(%) 6
Announcement Date 19-Sep-2013 Ex Dividend Date 19-Sep-2013 Dividend(%) 6
Announcement Date 20-Sep-2012 Ex Dividend Date 20-Sep-2012 Dividend(%) 6
Announcement Date 22-Sep-2011 Ex Dividend Date 22-Sep-2011 Dividend(%) 6
Announcement Date 23-Sep-2010 Ex Dividend Date 23-Sep-2010 Dividend(%) 12
Announcement Date 17-Sep-2009 Ex Dividend Date 17-Sep-2009 Dividend(%) 12
Announcement Date 18-Sep-2008 Ex Dividend Date 18-Sep-2008 Dividend(%) 12
Announcement Date 20-Sep-2007 Ex Dividend Date 20-Sep-2007 Dividend(%) 12
Bonus
No Bonus has been declared by LINCOLN
Splits
Record Date 26-Mar-2009 Split Date 19-Mar-2009 Face Value (Before/After) 2.00/10.00
Others
Rights No Rights has been declared by LINCOLN
Lincoln Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Lincoln Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Lincoln Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Lincoln Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Lincoln Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 93.02 Mar 2024 63.24 Mar 2023 39.16 Mar 2022 76.18 Mar 2021 71.41
PARTICULARS Investing Activities Mar 2025 -78.95 Mar 2024 -57.34 Mar 2023 -36.64 Mar 2022 -78.08 Mar 2021 -64.91
PARTICULARS Financing Activities Mar 2025 -6.40 Mar 2024 -5.18 Mar 2023 -4.50 Mar 2022 -2.56 Mar 2021 -5.29
PARTICULARS Net Cash Flow Mar 2025 7.67 Mar 2024 0.73 Mar 2023 -1.99 Mar 2022 -4.46 Mar 2021 1.20
Lincoln Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Lincoln Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 49.78%
Public 45.49%
Other Institutions 0.01%
FII 4.73%
Mutual Funds null%
About Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others.The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 2021-22, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022. The Company commenced commercial production in Mehsana in FY 2025.
Chairman (Non-Executive)
Kishorbhai M Shah
Registered office Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060
FAX :91-079-67778000
Background
Incorporation Year 1995
Face Value ₹10.00
Market Lot 1
FAQs on Lincoln Pharmaceuticals Ltd
How to buy Lincoln Pharmaceuticals Ltd shares on NSE?
To buy Lincoln Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Lincoln Pharmaceuticals Ltd share price today?
The Lincoln Pharmaceuticals Ltd share price on NSE is ₹529.10 today.
What is the market cap of Lincoln Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹1059.77.
What is the PE & PB ratio of Lincoln Pharmaceuticals Ltd?
PE is 13 and PB is 40.
What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd shares?
Lincoln Pharmaceuticals Ltd stock price high: ₹979.50 Lincoln Pharmaceuticals Ltd stock price low: ₹490.